Source: Annual Congress 2010 - Proteases and the matrix
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Lara, R. Verhoosel, J. Schrumpf, P. Hiemstra, J. Stolk, M. Miravitlles (Lleida, Barcelona, Spain; , Netherlands). Alpha-1 antitrypsin deficiency (AATD) and airway imflammation: Methods to study endoplasmatic reticulum stress (ERS). Eur Respir J 2010; 36: Suppl. 54, 4368

Member's Comments

No comment yet.

Related content which might interest you: Alpha-1 antitrypsin (AAT) in cystic fibrosis-associated endoplasmic reticulum (ER) stress Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 F alpha-1 antitrypsin polymerization activates endoplasmic reticulum overload response Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010 Endoplasmic reticulum stress in COPD: implications for alpha1-antitrypsin deficiency Source: Annual Congress 2011 - The unfolding story of endoplasmic reticulum stress signalling in lung disease Year: 2011 Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD) Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD) Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Alpha-1 antitrypsin (AAT) polymerization in alveolar macrophages of AAT deficient individuals and in smokers. Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD) Source: Eur Respir J 2006; 28: Suppl. 50, 223s Year: 2006 The effect of posture on ventilation using SLP in healthy subject and patients with Alpha 1 anti-trypsin deficiency (A1AT) Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Oxidative stress in serum of patients with alpha-1 antitrypsin deficiency Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011